scholarly article | Q13442814 |
P2093 | author name string | S A Moser | |
W E Goldman | |||
E R Unanue | |||
L N Heiss | |||
P2860 | cites work | Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells | Q24604169 |
Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro | Q24645085 | ||
Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. | Q33636477 | ||
Interleukin 1 is an autocrine regulator of human endothelial cell growth | Q33757605 | ||
IL-1 and its receptor are translocated to the nucleus | Q33837186 | ||
Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. | Q34391163 | ||
Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis | Q34449142 | ||
Selective cytokine production by epithelial cells following exposure to Escherichia coli | Q34524304 | ||
Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis | Q35112080 | ||
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium | Q37494553 | ||
Identification of a membrane-associated interleukin 1 in macrophages | Q37678410 | ||
Somnogenic activity of immune response modifiers | Q37806390 | ||
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. | Q37953740 | ||
Interleukin-1 and its biologically related cytokines | Q38198967 | ||
Pathogenesis of Infection with Bordetella pertussis in Hamster Tracheal Organ Culture | Q40092263 | ||
Muramyl Peptides as Possible Endogenous Immunopharmacological Mediators | Q40164050 | ||
Muramyl peptides: Immunomodulators, sleep factors, and vitamins | Q40178426 | ||
Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide | Q40858077 | ||
The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues | Q40994599 | ||
Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha | Q41758249 | ||
The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts | Q42808187 | ||
Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. | Q47232034 | ||
Purification and characterization of human recombinant precursor interleukin 1 beta. | Q54734733 | ||
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. | Q54779219 | ||
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
Pertussis | Q67328111 | ||
Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis | Q67983209 | ||
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta | Q68093928 | ||
Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity | Q68098182 | ||
Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer | Q68568858 | ||
Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides | Q68805455 | ||
Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides | Q68822541 | ||
Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides | Q69617657 | ||
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells | Q69749410 | ||
Induction of human interleukin-1 by toxic-shock-syndrome toxin-1 | Q69865427 | ||
Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts | Q70054667 | ||
Selective isolation and culture of a proliferating epithelial cell population from the hamster trachea | Q71511901 | ||
Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor | Q72077756 | ||
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2 | Q72820239 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytopathology | Q1881849 |
P304 | page(s) | 3123-3128 | |
P577 | publication date | 1993-08-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis | |
P478 | volume | 61 |
Q39655040 | A lytic transglycosylase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production |
Q36671660 | Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis |
Q34383541 | Bordetella pertussis pathogenesis: current and future challenges |
Q24675926 | Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro |
Q34937361 | Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis |
Q34007570 | Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae |
Q57158084 | Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens |
Q35548743 | Keratinocyte proinflammatory responses to adherent and nonadherent group A streptococci. |
Q24522458 | Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies |
Q42949822 | Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis |
Q36672962 | Mutations in ampG or ampD affect peptidoglycan fragment release from Neisseria gonorrhoeae |
Q59813480 | Pathogenesis of and the Host Defense in Ascending Infections of Human Fallopian Tube |
Q64106873 | Peptidoglycan Muropeptides: Release, Perception, and Functions as Signaling Molecules |
Q37123794 | Peptidoglycan fragment release from Neisseria meningitidis |
Q30406104 | Pertussis pathogenesis--what we know and what we don't know |
Q30251684 | Pertussis: Microbiology, Disease, Treatment, and Prevention |
Q34007024 | Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin |
Q39514484 | Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. |
Q61805094 | The Pathogenic Neisseria Use a Streamlined Set of Peptidoglycan Degradation Proteins for Peptidoglycan Remodeling, Recycling, and Toxic Fragment Release |
Q30358384 | The immune profile associated with acute allergic asthma accelerates clearance of influenza virus |
Q36142871 | The lytic transglycosylases of Neisseria gonorrhoeae |
Q33178523 | The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. |
Search more.